Where on my body should I inject tirzepatide?
Tirzepatide's three approved injection sites are the abdomen, outer thigh, and upper arm. Rotation matters more than site choice — here's how to do it right.
Updated May 29, 2026 · 4 min read
Tirzepatide (Mounjaro, Zepbound) is injected subcutaneously — into the fatty tissue under the skin — at one of three FDA-approved locations: the abdomen, the outer thigh, or the upper arm. All three sites are clinically equivalent for absorption and efficacy. Rotation matters more than which site you choose: repeatedly injecting the same spot leads to lipohypertrophy, a hardening of tissue that slows absorption unpredictably.
The three approved sites in detail
Abdomen The most commonly used site. Inject into the fatty tissue anywhere around the abdomen, except:
- Stay at least 2 inches (5 cm) away from the navel in all directions
- Avoid the area directly around the belly button — the tissue there is different and absorption is less reliable
- Avoid scars, stretch marks, and bruised or irritated skin
The abdomen is accessible without contortion, has plentiful subcutaneous tissue in most people, and tends to be straightforward once you're comfortable with the technique. Many users start here and stay here.
Outer thigh Inject into the outer, upper portion of the thigh — the lateral surface, about midway between the knee and hip. Avoid the inner thigh and the front-facing surface directly above the kneecap.
The thigh is a good secondary site, particularly useful for people who prefer visual confirmation when injecting. It can be slightly more painful than the abdomen for some users due to differences in subcutaneous fat distribution and nerve density. This is individual — others report no difference.
Upper arm The back or outer surface of the upper arm, in the triceps region. Reaching this site unassisted is genuinely difficult — most people need a mirror, a second set of hands, or some flexibility to inject here solo. It's most practical for people who have a partner who can help, or for self-injection with significant shoulder mobility.
When accessible, the upper arm is frequently reported as the least painful of the three sites. If you can manage the reach, it's worth trying.
Which site is least painful?
Pain varies considerably by person, site, and technique. General patterns:
| Site | Pain reports | Access difficulty |
|---|---|---|
| Abdomen | Moderate — most common starting site | Easy |
| Outer thigh | Moderate to higher | Easy |
| Upper arm | Often lower | Moderate-to-hard (solo) |
Several factors matter more than site choice:
- Skin temperature: cold skin hurts more. Let the pen warm to room temperature (30 minutes out of the fridge) before injecting
- Speed: slow insertion is often more painful than confident, deliberate insertion
- Don't rub: rubbing after the injection increases local irritation. The instructions say to apply gentle pressure — not massage
The auto-injector (KwikPen for Mounjaro, semaglutide autoinjectors) means you're not controlling needle insertion speed manually. Most users adapt to this quickly.
Rotation: the most important rule
Injecting the same spot every week creates a cumulative problem. The subcutaneous tissue becomes fibrotic — dense and hardened — which is called lipohypertrophy. It usually doesn't hurt, which is why people keep using the spot. But hardened tissue absorbs drugs unpredictably; injecting into lipohypertrophy can significantly reduce tirzepatide's effectiveness.
Rotation strategy:
-
Rotate within each zone first. The abdomen, for example, has substantial surface area. Don't use the same 1-inch spot every week — move to a different location within the abdomen each injection. Imagine the abdomen divided into quadrants; cycle through them.
-
Rotate between zones over time. Alternating between abdomen and thigh across consecutive weeks distributes the injection burden and lets each site recover more fully.
-
Keep a simple log. Even a note in your phone ("L abdomen upper-right" this week) helps avoid re-using the same spot too soon. Some users put a small mark with a marker after injection to remind themselves where they were last.
-
Inspect before injecting. Before each injection, look at and feel the area you plan to use. If it feels firm, noticeably different from surrounding tissue, or has visible changes, skip it and choose another spot.
What to avoid
- Skin that is red, irritated, bruised, or broken — injection into compromised skin increases infection risk and changes absorption
- Directly over moles, scars, or tattoos — these don't preclude nearby injection but aren't ideal sites themselves
- The area 2 inches around the navel (for abdomen)
- Intramuscular injection — this isn't subcutaneous, it hurts more, and absorption kinetics are different. Subcutaneous means a gentle pinch of tissue; if you're fully tensing a muscle, you're probably too deep
- Sharing injection sites with other medications — if you're also injecting insulin or another drug, don't use the same spot at the same time. Give each drug its own rotation pattern
If a site becomes uncomfortable over time
Some users develop site reactions — redness, itching, or firmness — at frequently used locations. Taking that site out of rotation entirely for 4–6 weeks usually resolves it. If a site stays visibly changed (hard nodule, persistent redness) for more than a few weeks, mention it to your prescriber; lipohypertrophy that's already established takes longer to resolve and occasionally warrants a clinical look.